The COVID-19 outbreak is an emerging and rapidly evolving situation and health professionals need up-to-date information to effectively manage the threat of the disease.
Coronavirus nCoV2019 is a novel pathogen which is spreading in an unprecedented way in China and the region. Cases are already arising in Europe and other countries - and it is difficult to predict the full healthcare, social and economic consequences. Therefore there is a crucial need for respiratory team members to gain knowledge about this pathogen and to prepare an adequate clinical response to the threat.
The ERS, in collaboration with PREPARE EU project and ECDC, have put together a unique resource in this webinar to give to all respiratory team members an update on the virology, epidemiology, clinical consequences and research potential. We are fortunate to have a selected team of renowned experts to:
a) Describe current activity in managing coronavirus in China b) Discuss epidemiology C) Discuss relevant clinical trials in providing quick therapeutic responses
Not to be missed for any member of the respiratory team who needs to be prepared to manage this health threat.
Recorded sessions made based on questions collected from ERS members and made available for the community of healthcare professional. Questions are organised as follows: a) Epidemiology, b) Clinical experience, c) Research potential in providing quick therapeutic response. ICU response including the REMAP-CAP trial (funded by PREPARE).
The session will cover the most recent information on epidemiology, risk assessment, virology and case definitions, clinical management, outcomes, research potential and ICU care, including the REMAP-CAP trial.
Following these webinars, participants will be able to:
- Demonstrate an updated understanding of this major health threat which may impact on their practice.